The fifth annual Mental Health Action Day, is an initiative spearheaded by SHOWTIME/MTV Entertainment Studios and TaskForce that brings together thousands of organisations and brands. The goal of this global movement is to shift the focus from awareness to action regarding mental health. A key element promoted this year is the A.S.K. framework (Acknowledge, Support, Keep-in-Touch) for providing emotional support. Several examples are provided of how Paramount Global and its partners, including local CBS stations and popular television shows, are supporting non-profits and encouraging communities to take concrete steps for mental well-being through various local events and initiatives. Continue reading
Category Archives: Health
Everyone isn’t ‘a little bit autistic’ – here’s why this notion is harmful
Aimee Grant, Swansea University
I recently had a medical appointment and explained that I’m autistic. It affects how I communicate and understand information, and sometimes I’m misinterpreted as being rude. The person nodded and replied: “Well, everyone’s a little bit autistic.” They then shared something they struggle with, sometimes, when they haven’t had enough sleep.
Women’s Heart Health: Medtronic Survey and Campaign
May 7, 2025 /Mpelembe Media/ — A Medtronic-sponsored survey highlighted a significant lack of discussion and awareness regarding heart health among women aged 30-50 in the US, despite cardiovascular disease being the leading cause of death for women. Continue reading
Elsevier adds half a million records from ClinicalTrials.gov to Embase, enabling a seamless search experience in the world’s most comprehensive biomedical database
Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, Embase. The integration will enable researchers to seamlessly view high-quality information on clinical research studies and their results alongside the peer-reviewed literature, in-press publications and conference abstracts already available in Embase. Continue reading
Insights into Alcohol Use Disorder Diagnosis and Treatment
May 1, 2025 /Mpelembe Media/ — A new online survey conducted by The Harris Poll on behalf of Alkermes, Inc., a biopharmaceutical company focused on neuroscience, explores the experiences of individuals diagnosed with Alcohol Use Disorder (AUD). Continue reading
GammaPod revolutionizes breast cancer treatment: Italy introduces high-dose stereotactic radiotherapy in a single session to Europe
GammaPod represents a true revolution in the treatment of breast cancer: it allows the safe and precise administration of high doses of radiation to the tumor because, unlike conventional radiotherapy equipment, designed to treat tumors in all areas of the body, GammaPod was invented and designed to treat only breast cancer. Continue reading
Weekly Recap: 15 Health Press Releases You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including the first use of Johnson & Johnson’s robotic surgical system and a staggering global statistic on pediatric antimicrobial resistance. Continue reading
AI-Assisted Nursing: A New Research Project
Jan. 23, 2025 /Mpelembe Media/ — A Finnish research project, part of the European ITEA PROFIT initiative, explores using artificial intelligence to alleviate the workload of nurses. The project aims to develop AI tools for tasks like patient registration and information review, freeing up nurses for direct patient care. Continue reading
BAIBYS™: AI-Powered IVF System
Jan. 14, 2025 /Mpelembe Media/ — BAIBYS™, an Israeli startup, announced its CE-marked AI-powered robotic system for autonomous sperm selection in IVF. This system uses AI and machine vision to identify and isolate optimal sperm cells, addressing the growing global issue of male infertility. Continue reading
AI-powered tool aids in the early detection of melanoma
Jan. 6, 2025 /Mpelembe Media/ — , a medical technology company, is partnering with the Mayo Clinic to pilot its Nevisense device in the US. Nevisense, an FDA-approved AI-powered tool, aids in the early detection of melanoma, the deadliest form of skin cancer. Continue reading